3M delivered better-than-expected results in Q1 2024, returning to organic growth and achieving double-digit adjusted earnings growth. The company completed the spin-off of Solventum and finalized major legal settlements, positioning it for long-term shareholder value creation.
Sales of $8.0 billion, down 0.3% year-over-year; adjusted sales of $7.7 billion with organic growth up approximately 1% year-over-year.
GAAP earnings per share of $1.67, down 5% year-over-year; adjusted earnings of $2.39, up double digits year-over-year.
Successfully completed the spin of Solventum on April 1st.
Initiated full-year 2024 guidance reflecting completion of Solventum spin.
3M initiated full-year 2024 expectations, reflecting Solventum as a discontinued operation. Adjusted total sales growth is expected to be between -0.25% and +1.75%, with adjusted organic sales growth flat to +2%. Adjusted earnings per share are projected to be between $6.80 and $7.30.